Segmental Bone Reconstruction

Custom-printed structural spacers designed for large-segment bone loss due to high-energy trauma, oncology, or chronic infection.

Client:

Advanced Limb Salvage Center

Date:

January 2026

Clinical Overview: The Challenge of Critical-Sized Defects

Segmental bone defects, often defined as voids greater than 2cm or those exceeding 50% of the bone diameter, do not heal through natural physiological processes. These "critical-sized" defects, resulting from radical tumor resection, severe comminuted fractures, or debridement of osteomyelitis, traditionally required aggressive bone grafting or long-term external fixation. The Segmental Bone Reconstruction application utilizes 3D-printed titanium spacers to provide immediate mechanical stability and a biological bridge for long-term limb salvage.

Biomechanical Engineering and Load Distribution

Unlike solid metallic rods, which can lead to stress shielding and subsequent bone atrophy, our segmental spacers are engineered with a gradient of porosity. This ensures that the implant shares the physiological load with the surrounding native bone, promoting health rather than resorption.

  • Internal Channeling: Spacers can be designed with hollow internal architectures or central "canals" to allow for the placement of intramedullary nails or to support bone transport techniques (Distraction Osteogenesis).
  • Anatomical Contouring: Using CT-based reconstruction, the proximal and distal interfaces of the spacer are matched precisely to the patient’s bone ends. This maximized surface area contact is critical for reducing peak stresses at the interface.
  • Torsional Stability: Engineered "fins" or locking mechanisms can be integrated into the design to prevent rotation within the medullary canal, providing superior initial stability.

Advanced Surface Technology for Biological Fixation

A successful segmental reconstruction depends on the biological "handshake" between the metal and the host bone. This application utilizes Laser Powder Bed Fusion (LPBF) to create a dual-surface environment.

  1. Macro-Architecture: Large-scale pores allow for the packing of autograft or bone morphogenetic proteins (BMPs) within the spacer to jumpstart the healing process.
  2. Micro-Architecture: The 3D-printed titanium surface features a specific micro-roughness that encourages protein adsorption and early osteoblast attachment.
  3. Lattice Optimization: The interconnected nature of the porous scaffold ensures that once bone in-growth begins, it can move entirely through the device, creating a true biological-mechanical composite.

Clinical Applications in Oncology and Trauma

The ability to print "on-demand" anatomical spacers has transformed the surgical timeline for limb salvage. In oncology cases, the spacer can be designed and printed during the pre-operative planning phase, allowing for immediate reconstruction following tumor resection.

Key Clinical Advantages:

  • Restoration of Limb Length: Precisely corrects for bone loss to prevent gait abnormalities and pelvic tilt.
  • Limb Salvage vs. Amputation: Provides a viable option for patients who would otherwise face amputation due to the size or location of a bone void.
  • Reduced Donor-Site Morbidity: By providing a structural alternative to massive autografts, the patient avoids the pain and complications associated with secondary harvest sites.

Summary of Evidence and Structural Validation

Every segmental reconstruction device undergoes rigorous finite element analysis (FEA) to ensure it can withstand the repetitive cycles of human ambulation. By adhering to strict FDA regulatory pathways and leveraging evidence-based innovation, this application provides a validated, high-fidelity solution for the most complex bone reconstruction challenges in modern surgery.

Partner with Additive Orthopaedics today.

Join a trusted ecosystem dedicated to the advancement of 3D-printed implant technologies. We transform complex anatomical challenges into clinical successes through evidence-based innovation and regulatory transparency.

Clinically Validated
Innovation-Driven
Regulatory-Aware